Summary: Applied Pharmacoeconomic and
Outcomes Research Forum
Spring 2007
1.AMCP Dossiers: Useful for Decision
Making or Not? A Debate
2.Biologics: Drawing (or Crossing) the
line of Cost vs. Benefit: A Case in
Oncology
3.Quality Adjusted Life Years (QALY's)
for Decision Making: Views from
Canada and the U.S.
Third Forum
· Discuss commonly encountered obstacles to
conducting or utilizing results of PE studies for
decision making
· Explore solutions from various perspectives
·Managed Care
·Government
·Pharmaceutical/Biotech Firms
·Medical Centers

Source: Abagyan, Ruben - School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego

Collections: Biology and Medicine